Victory Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.1K | Buy |
17,824
+1,563
| +10% | +$1.77K | ﹤0.01% | 2442 |
|
|
2025
Q1 | $23.7K | Sell |
16,261
-1,380
| -8% | -$2.02K | ﹤0.01% | 2420 |
|
|
2024
Q4 | $37.6K | Buy |
17,641
+262
| +2% | +$558 | ﹤0.01% | 2414 |
|
|
2024
Q3 | $48.7K | Sell |
17,379
-318
| -2% | -$890 | ﹤0.01% | 2394 |
|
|
2024
Q2 | $41.2K | Buy |
17,697
+4,022
| +29% | +$9.37K | ﹤0.01% | 2383 |
|
|
2024
Q1 | $61.1K | Sell |
13,675
-608
| -4% | -$2.72K | ﹤0.01% | 2358 |
|
|
2023
Q4 | $45.8K | Buy |
14,283
+2,680
| +23% | +$8.6K | ﹤0.01% | 2446 |
|
|
2023
Q3 | $36.8K | Buy |
+11,603
| New | +$36.8K | ﹤0.01% | 2406 |
|
|
2022
Q3 | – | Sell |
-14,525
| Closed | -$166K | – | 2701 |
|
|
2022
Q2 | $166K | Buy |
14,525
+190
| +1% | +$2.17K | ﹤0.01% | 2391 |
|
|
2022
Q1 | $120K | Buy |
14,335
+1,688
| +13% | +$14.1K | ﹤0.01% | 2492 |
|
|
2021
Q4 | $189K | Sell |
12,647
-363
| -3% | -$5.43K | ﹤0.01% | 2493 |
|
|
2021
Q3 | $334K | Sell |
13,010
-47,258
| -78% | -$1.21M | ﹤0.01% | 2346 |
|
|
2021
Q2 | $1.57M | Sell |
60,268
-888,591
| -94% | -$23.2M | ﹤0.01% | 1704 |
|
|
2021
Q1 | $33.5M | Sell |
948,859
-67,193
| -7% | -$2.37M | 0.03% | 719 |
|
|
2020
Q4 | $25.6M | Sell |
1,016,052
-195,611
| -16% | -$4.94M | 0.03% | 773 |
|
|
2020
Q3 | $45.7M | Buy |
1,211,663
+143,215
| +13% | +$5.4M | 0.06% | 493 |
|
|
2020
Q2 | $45.8M | Buy |
1,068,448
+1,048,110
| +5,153% | +$44.9M | 0.06% | 452 |
|
|
2020
Q1 | $396K | Buy |
20,338
+7,974
| +64% | +$155K | ﹤0.01% | 2160 |
|
|
2019
Q4 | $321K | Buy |
12,364
+3,610
| +41% | +$93.7K | ﹤0.01% | 2182 |
|
|
2019
Q3 | $239K | Buy |
+8,754
| New | +$239K | ﹤0.01% | 2159 |
|